Eve Clear Scan in the News
January 4, 2021
SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies
Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount ... Read more...
Read more...February 8, 2021
SmartBreast™ Buys Molecular Breast Imaging Assets from GE Healthcare
SmartBreast Corporation (SmartBreast™), a privately held company with headquarters near Pittsburgh, US and offices in Los Angeles, US and Taipei, Taiwan, focused on breast cancer screening and diagnosis, has announced that it has acquired the Discovery NM750b Healthcare ... Read more...
Read more...February 9, 2021
SmartBreast™ Announces Molecular Breast Imaging Partnership with FITI
SmartBreast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and diagnosis, announced today that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. (FITI) to manufacture Molecular Breast Imaging (MBI) systems ... Read more...
Read more...March 18, 2022
SmartBreast™ Presents at the 2022 LSI: Emerging Medtech Summit
SmartBreast™ presented to investors at the third annual Life Science Intelligence (LSI) USA 22 Emerging Medtech Summit, where it proposed investment funding opportunities and explored partnerships with startup companies that have developed AI (artificial intelligence) software to enhance dense-breast imaging ... Read more...
Read more...